165 related articles for article (PubMed ID: 32736785)
21. Venous thromboembolism risk and prophylaxis prescription in surgical patients at a tertiary hospital in Eastern Cape Province, South Africa.
Rocher WD; Page T; Rocher M; Nel D
S Afr Med J; 2019 Feb; 109(3):178-181. PubMed ID: 30834875
[TBL] [Abstract][Full Text] [Related]
22. Venous Thromboembolism Prophylaxis and Risk in the Inpatient and Outpatient Continuum of Care Among Hospitalized Acutely Ill Patients in the US: A Retrospective Analysis.
Amin A; Neuman WR; Lingohr-Smith M; Menges B; Lin J
Adv Ther; 2019 Jan; 36(1):59-71. PubMed ID: 30543037
[TBL] [Abstract][Full Text] [Related]
23. Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study.
Figueroa R; Alfonso A; López-Picazo J; Gil-Bazo I; García-Mouriz A; Hermida J; Páramo JA; Lecumberri R
PLoS One; 2018; 13(8):e0200220. PubMed ID: 30071038
[TBL] [Abstract][Full Text] [Related]
24. American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
Lyman GH; Khorana AA; Falanga A; Clarke-Pearson D; Flowers C; Jahanzeb M; Kakkar A; Kuderer NM; Levine MN; Liebman H; Mendelson D; Raskob G; Somerfield MR; Thodiyil P; Trent D; Francis CW;
J Clin Oncol; 2007 Dec; 25(34):5490-505. PubMed ID: 17968019
[TBL] [Abstract][Full Text] [Related]
25. Risk of Thrombosis in Cancer: Clinical Factors and Role of Primary Prophylaxis.
Roopkumar J; Khorana AA
Cancer Treat Res; 2019; 179():55-68. PubMed ID: 31317480
[TBL] [Abstract][Full Text] [Related]
26. Prevention of venous thromboembolism in hospitalized patients with cancer.
Francis CW
J Clin Oncol; 2009 Oct; 27(29):4874-80. PubMed ID: 19704060
[TBL] [Abstract][Full Text] [Related]
27. The additional benefit of graduated compression stockings to pharmacologic thromboprophylaxis in the prevention of venous thromboembolism in surgical inpatients.
Mandavia R; Shalhoub J; Head K; Davies AH
J Vasc Surg Venous Lymphat Disord; 2015 Oct; 3(4):447-455.e1. PubMed ID: 26992625
[TBL] [Abstract][Full Text] [Related]
28. Venous thromboembolism prophylaxis after hospital discharge: transition to preventive care.
Kaatz S; Spyropoulos AC
Hosp Pract (1995); 2011 Aug; 39(3):7-15. PubMed ID: 21881387
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
30. Lack of evidence to support thromboprophylaxis in hospitalized medical patients with cancer.
Carrier M; Khorana AA; Moretto P; Le Gal G; Karp R; Zwicker JI
Am J Med; 2014 Jan; 127(1):82-6.e1. PubMed ID: 24384102
[TBL] [Abstract][Full Text] [Related]
31. Thromboprophylaxis in nonsurgical patients.
Streiff MB; Lau BD
Hematology Am Soc Hematol Educ Program; 2012; 2012():631-7. PubMed ID: 23233645
[TBL] [Abstract][Full Text] [Related]
32. Considerations for pharmacologic thromboprophylaxis following inpatient brachytherapy for gynecologic malignancies.
McAlarnen LA; Small C; Tostrud L; Pan AY; Erickson B; Bedi M; Bradley WH
Brachytherapy; 2023; 22(5):630-639. PubMed ID: 37394350
[TBL] [Abstract][Full Text] [Related]
33. Venous thromboprophylaxis in gastrointestinal bleeding.
Malhotra N; Chande N
Can J Gastroenterol Hepatol; 2015 Apr; 29(3):145-8. PubMed ID: 25855878
[TBL] [Abstract][Full Text] [Related]
34. Overuse of venous thromboembolism prophylaxis among hospitalized patients with liver disease.
Davis JPE; O'Leary KE; Intagliata NM
Eur J Haematol; 2020 Mar; 104(3):223-229. PubMed ID: 31797441
[TBL] [Abstract][Full Text] [Related]
35. To prophylax or not, and how much and how long? Controversies in VTE prevention for medical inpatients, including COVID-19 inpatients.
Spyropoulos AC
Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):506-514. PubMed ID: 36485109
[TBL] [Abstract][Full Text] [Related]
36. Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.
Huo MH; Muntz J
Clin Ther; 2009 Jun; 31(6):1129-41. PubMed ID: 19695383
[TBL] [Abstract][Full Text] [Related]
37. The NCCN Clinical Practice Guidelines on Venous Thromboembolic Disease: strategies for improving VTE prophylaxis in hospitalized cancer patients.
Khorana AA
Oncologist; 2007 Nov; 12(11):1361-70. PubMed ID: 18055857
[TBL] [Abstract][Full Text] [Related]
38. Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era.
MacDougall K; Spyropoulos AC
Semin Respir Crit Care Med; 2021 Apr; 42(2):308-315. PubMed ID: 33548931
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulation for prevention and treatment of cancer-related venous thromboembolism.
Barsam SJ; Patel R; Arya R
Br J Haematol; 2013 Jun; 161(6):764-77. PubMed ID: 23560605
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacological Thromboprophylaxis in Acutely Ill Hospitalized Medical Patients].
Kantor B; Poénou G; Plaisance L; Toledano E; Mekhloufi Y; Helfer H; Djennaoui S; Mahé I
Rev Med Interne; 2022 Jan; 43(1):9-17. PubMed ID: 33895004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
